Compliant with microbial limit tests of JP, USP, and EP. Delivering fresh culture media from our domestic factory.
"Columbia Agar" is used for the isolation and cultivation of bacteria with strict nutritional requirements from various samples, as well as general bacteria. The combination of casein pancreatic digest, pepsin digest of animal tissue, and beef extract allows for good bacterial growth. Yeast extract serves as a source of B-complex vitamins and, along with corn starch, plays a role as an energy source. [Features] - Convenient packaging with 5 sheets in 2 packs - Anaerobic packaging that can be used immediately after opening - Shelf life of 6 months - Refrigerated storage (2–8°C) - Complies with the three pharmacopoeias (JP, USP, EP) *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Composition (per 1L of purified water)】 ■ Casein pancreatin digest: 12.0 g ■ Animal tissue pepsin digest: 5.0 g ■ Yeast extract: 3.0 g ■ Beef extract: 3.0 g ■ Corn starch: 1.0 g ■ Sodium chloride: 5.0 g ■ Agar: 13.5 g ■ Final pH = 7.3 ± 0.2 *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■Isolation and culture of bacteria with strict nutritional requirements and general bacteria from various samples. *For more details, please refer to the PDF document or feel free to contact us.*
catalog（1）
Download All Catalogs
Company information
BD Japan is the Japanese subsidiary of BD, one of the world's leading medical device and medtech companies headquartered in New Jersey, USA. BD aims to lead the world in medical technology, seeking new insights in the healthcare field and improving the quality of diagnosis and treatment, with the purpose of realizing "The future of healthcare for all(TM)." By developing innovative technologies and services related to patient treatment and healthcare processes, BD supports those working on the front lines of healthcare. With approximately 77,000 employees worldwide, BD staff support researchers in the development of next-generation diagnostic and therapeutic methods and strive daily to enhance the safety of healthcare professionals and the efficiency of medical practices in clinical settings. By partnering with healthcare institutions in countries around the world and addressing global priority issues, BD contributes to improving healthcare outcomes, reducing costs, increasing efficiency, enhancing safety, and promoting access to healthcare through close collaboration with its customers, the healthcare institutions.
![[Case Study on Culture Media] Establishing a Liquid Culture Media Supply System for a Major Biopharmaceutical Company](https://image.mono.ipros.com/public/default/object/noimage_l.gif?w=280&h=280)